Marie Hasselluhn
@MC_Hasselluhn
Followers
899
Following
4K
Media
104
Statuses
323
Associate Research Scientist @ Columbia University Medical Center | Pancreatic cancer research | Dedication/Craziness/Passion | Nature enthusiast
Joined November 2018
Great message from Tony Hollingsworth to all of us: “We need to review grant applications as if we submitted them.” We need to be able to publish negative results to avoid redundancy and effectively make progress in #PancreaticCancer research. #AACR22
2
22
173
Check out this opportunity for planning your next career step!.
0
0
1
Check out this ground breaking work on pancreatic 3D organoid structures by @arispapargyriou in the @MaxReichertMD lab!.
Paper alert!! 🥳😁.I am over the moon to share the biggest (and best) part of my #phd in @MaxReichertMD lab at @TU_Muenchen #phdvoice #phdchat.A work that started almost 5 years ago, is finally out in @natBME .Let’s break it down together 1/ 🧵.
0
3
16
On #WorldPancreaticCancerDay I am reminded why I am doing the job I love, even though the days are long and full of struggles. We are working every day on understanding #PancreaticCancer a little better to identify new targets for better, personalized therapeutical approaches.
1
2
33
Why do we need Night Science and why is creativity not taught in science education? @ItaiYanai and @StearnsLab are asking us to take a step back from hypothesis testing and develop our creative, improvisational skills - crucial for generating research ideas as a #FuturePI.
4
10
84
I am honored to announce that NCI puts a lot of faith in me, my science, and my vision for the future. I am excited to work together with the leading scientists of tomorrow to create an inclusive work environment that fosters the interests of every lab member. Stay tuned!.
Really excited for my postdoc @MC_Hasselluhn who received a 4th percentile score on her K99 application. Folks, she's on the job market!.
14
1
67
I am delighted I had the chance to meet @CterminiPhD in NYC! Not only did she provide guidance on the transition to independence during trainee lunch but also presented her exciting work about Syndecan-2. Thank you for the great opportunity!
2
0
19
Let’s start a debate! Have we learned anything from working with KRAS inhibitors that we didn’t learn from mice? @Pasca_Lab takes the lead by reintroducing the KRAS* model system for #PancreaticCancer. #AACRPan24
1
2
11
Kamiya Mehla concludes the session on metabolism in #PancreaticCancer with her perspective on how the innate immune response is shaped by metabolic competition. #AACRPan24
0
0
3
#PancreaticCancer is highly reliant on autophagy. Why are autophagy inhibitors not delivering promising results in vivo? @LyssiotisLab demonstrates an amazing synthetic lethality strategy using PIKfyve inhibition to eradicate the tumor, check out @DJCalebC’s preprint! #AACRPan24
0
7
18
The #PancreaticCancer microenvironment is sparse in nutrients. @AlecKimmelman talks about Serine deprivation and how cancer cells overcome nutrient restriction by communicating with stromal cells. #AACRPan24
0
2
6
Harsh Singh demonstrates a huge (!) study using NGS profiling on over 8,700 #PancreaticCancer patients to find predictors of chemotherapeutic response associated with basal or classical subtype. #AACRPan24
1
0
8
Nicholas T. Woods seeks to determine molecular subtypes by focusing on the proteome as opposed to the transcriptome. Optimal #PancreaticCancer patient stratification would lead to optimized treatment options and better outcomes. Way to go! #AACRPan24
0
0
6
An amazing group of researchers! I am looking forward to future collaborations and scientific exchanges.
Also really enjoyed lunch with a developing ‘myeloid-fibroblast crosstalk’ working group in #PancreaticCancer involving some energetic rising stars in the field @DebVendramini @Lu_Han_PhD @MC_Hasselluhn @arianamusa @anna_bianchi22 et al. Missed you @NinaSteele17! #AACRPan24
0
0
5
How does metabolic stress affect stromal and epithelial plasticity? @Cosimo_Commisso demonstrates Glutamine depletion in #PancreaticCancer and its wide-ranging effects in the tumor microenvironment. #AACRPan24
0
1
11
Good morning, Boston! Stephanie Dougan introduces her profound work on TGFbeta blockade in #PancreaticCancer in the plasticity session of #AACRPan24.
0
0
11
Dr. Peter Allen from @DukeU asks important questions like: Am I the only one interested in understanding IPMN progression towards #PancreaticCancer? Well, I am interested in IPMNs too, and I am sure we aren’t the only ones in attendance. Right?! #AACRPan24
0
2
13
Christopher Counter from @DukeU starts with this impressive overview of RAS mutation tropism. In #PancreaticCancer there is a clear emphasis on KRAS G12D, however, that is not the case for other organs. What causes this divergence? #AACRPan24
0
0
8
Dr. Mallika Singh from Revolution Medicines introduces the mechanism of their RAS(ON) drug that targets all RAS variants and the wild type. A fantastic example for drug design! This gives hope to #PancreaticCancer patients. #AACRPan24
0
0
10
